Rise of the biological machines
This week synthetic biologist Paul Freemont, professor of protein crystallography at Imperial College London, argues that the future lies with highly efficient biological machines capable of manufacturing chemicals and drugs or capturing carbon from the atmosphere.He describes his vision of applying the principles of engineering to create purpose-built organisms from a catalogue of standard components in a controllable and predictable way. Measured against the early progress of electronics, synthetic biologists may still be in the 1950s, but Freemont points to the recent creation of yeast that manufacture the anti-malarial artemisinin and algae that produce biofuel as hopeful signs of what might be possible.Turning our gaze heavenwards, on the 40th anniversary of Apollo 11 we speak to the …
Similar Posts:
- Left Ventricular Function and C-Reactive Protein Levels in Acute Myocardial Infarction
- Cloning, overproduction, purification, crystallization and preliminary X-ray diffraction analysis of yeast glutaredoxin Grx5
- Cost-effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data
- Asymmetry of diurnal intraocular pressure fluctuation between right and left eyes
- Tolerability of Red Yeast Rice (2,400 mg Twice Daily) Versus Pravastatin (20 mg Twice Daily) in Patients With Previous Statin Intolerance
- Serum adiponectin acutely after an ischemic stroke: implications for a long-lasting, suppressed anti-inflammatory role
- Correlation Between Serum Cardiac Markers and Myocardial Infarct Size Quantified by Myocardial Perfusion Imaging in Patients With Hypertrophic Cardiomyopathy After Alcohol Septal Ablation
- IL-21 Seen as Critical to Immune System Antiviral Response (CME/CE)
- Improvements in Teen Sexual Health Waning (CME/CE)
- Improvements in Teen Sexual Health Waning (CME/CE)